Masimo is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. A key medical technology innovator, Masimo is responsible for the invention of award-winning noninvasive technologies that are revolutionizing patient monitoring, including Masimo SET® pulse oximetry, Masimo rainbow® SET Pulse CO-Oximetry and new Masimo noninvasive and continuous total hemoglobin (SpHb®) monitoring technology. These new rainbow® technologies are expected to open new markets and significantly expand the company’s growth opportunities. Joe Kiani founded Masimo in 1989 as a private "garage start-up" company because he was convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry.
Today, Masimo has grown into a successful publicly traded medical technology company employing over 2,500 people worldwide with product revenues that have increased 4-fold in the last five years. In addition, the company has technology license and OEM agreements with leading patient monitoring manufacturers spanning the globe including Atom, Datascope, GE Medical, Medtronic, Philips, Spacelabs, and Zoll. Masimo is not only the inventor of Measure-through Motion and Low Perfusion pulse oximetry and Pulse CO-Oximetry technologies, but is also the market-leading pulse oximetry technology solution.
In 1995, Masimo debuted Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo SET—a breakthrough in pulse oximetry technology that virtually eliminated false alarms and increased pulse oximetry’s ability to detect life-threatening events. More than 100 independent and objective studies demonstrate that Masimo SET provides the most reliable SpO2 and pulse rate measurements even under the most challenging clinical conditions, including patient motion and low peripheral perfusion.
In 2005, Masimo introduced rainbow® SET Pulse CO-Oximetry, a breakthrough noninvasive blood constituent monitoring platform that measures many blood constituents that previously required invasive procedures. Masimo rainbow SET continuously and noninvasively measures total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®) and pleth variability index (PVI®), in addition to oxyhemoglobin (SpO2), pulse rate (PR), and perfusion index (PI), enabling early detection and treatment of potentially life-threatening conditions.
For more than 20 years now, Masimo has been focused on a singular mission to create noninvasive patient monitoring technologies that are more effective and reliable and to improve patient outcomes and reduce the cost of care by bringing these technologies to new sites and applications. The result is a portfolio of clinically-proven products that lead the way in innovation, performance and patient safety by giving health care providers the information they need to optimize clinical decision-making.

Products
Events

Tue, 31 Aug 2021 - Fri, 3 Sep 2021
News
Masimo to Present in 20th Annual Needham Healthcare Conference
2021 07 Apr
Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the 20th Annual Needham Healthcare Conference on Monday, April 12, 2021 at 3:45 p.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. Read more
Study Investigates the Effects of Rescue Therapies on the Cerebral Oxygenation of COVID-19 Patients
2021 06 Apr
Study Stresses the Importance of Brain Monitoring During the Treatment of Patients with Severe COVID-19 Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in Critical Care in which researchers in Genoa, Italy, evaluated the impact of a variety of rescue therapies on the systemic and cerebral oxygenation... Read more
Study Investigates Impact of Automating Respiration Rate Measurement Using Masimo Rad-G™ with RRp®
2021 29 Mar
Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in Acta Paediatrica in which researchers from the Hospital for Sick Children in Toronto evaluated the accuracy of plethysmographic respiration rate measurement (RRp®) using Masimo Rad-G™, a rugged, handheld device, on malnourished, hospitalized children... Read more
Sri Lankan Study Expands Evidence of the Benefits of CCHD Screening Using Masimo SET® Pulse Oximetry
2021 22 Mar
Masimo today announced the results of a prospective study published in the Sri Lanka Journal of Child Health in which researchers in Colombo, Sri Lanka evaluated the efficacy of a pulse oximetry-based critical congenital heart disease (CCHD) newborn screening strategy using Masimo SET® pulse oximetry. 1 The authors concluded that pulse oximetry... Read more
FDA Clearance for Masimo O3® Regional Oximetry for Extended Use in Cerebral & Somatic Applications
2020 31 Aug
Masimo today announced that O3® Regional Oximetry has received FDA clearance for expanded use in monitoring somatic tissue oxygenation saturation in all patient populations and monitoring relative changes in hemoglobin, oxyhemoglobin, and deoxyhemoglobin in adult brains. With this FDA clearance, O3 is now indicated for use in both cerebral and somatic... Read more
New Studies Investigate the Accuracy of Masimo SpHb® on Neonates
2020 19 Aug
Masimo today announced that in a study recently published in the Journal of Tropical Pediatrics, researchers evaluating Masimo SpHb® (noninvasive, continuous hemoglobin monitoring) on neonatal patients concluded that the technology “offers reliable Hb [hemoglobin] values, which are comparable with the more traditional tHb [invasive venous blood... Read more
New Blinded Observational Study Shows Greater Depth of Sedation Than Intended During Colonoscopy
2020 03 Aug
Masimo SedLine® Brain Function Monitoring with PSi Processed EEG Helped Identify the Oversedations Masimo today announced that in a new study published in Anesthesia Research and Practice, researchers used Masimo SedLine® Brain Function Monitoring to investigate the depth of anesthesia of patients receiving propofol for outpatient colonoscopy,... Read more
Masimo Expands the Masimo SafetyNet™️ Solution with Continuous Body Temperature Measurement
2020 27 Jul
The Radius Tº™ Wearable Temperature Sensor Automates Remote Monitoring of Patient Temperature Status Masimo today announced a significant expansion to the Masimo SafetyNet™ platform with the introduction of Radius Tº™, a wearable, wireless sensor that provides continuous body temperature measurements. By augmenting the already powerful Masimo... Read more
New Study Expands Evidence of the Benefits of CCHD Screening Using Masimo SET® Pulse Oximetry
2020 20 Jul
Masimo today announced the results of a prospective study published in the International Journal of Neonatal Screening in which researchers in Marrakesh, Morocco, conducted the first Moroccan study on critical congenital heart disease (CCHD) screening for newborns using Masimo SET® pulse oximetry.1 The authors concluded that “Our results encourage... Read more
Masimo Announces UniView: 60™ Digital Charting Solution
2020 14 Jul
UniView: 60 Uses the Power of the Masimo Hospital Automation™ Platform to Improve Clinical Workflows and Hand-off Communication Masimo today announced its latest automation and connectivity solution, UniView: 60™. UniView: 60 uses the Masimo Hospital Automation™ platform to aggregate and display pertinent patient information on a digital display... Read more
Study Investigates Accuracy of Respiration Rate From Pulse Oximetry on Pediatrics Using Masimo RRp®
2020 06 Jul
Masimo today announced the results of a study published in Pneumonia in which independent researchers in New Delhi, India, investigated the accuracy of Masimo RRp® on pediatric patients with the Rad-G™ Pulse Oximeter by comparing it to clinician-determined values while performing routine assessment of children admitted to outpatient and emergency... Read more
Masimo Announces Bridge™
2020 29 Jun
Drug-free Neurostimulation Device Reduces the Symptoms of Opioid Withdrawal Masimo today announced Bridge™, an opioid withdrawal solution that uses neuromodulation to aid in the reduction of symptoms associated with opioid withdrawal. Bridge, which has been granted an FDA De Novo classification, is the first evidence-based, drug-free, non-surgical... Read more
Masimo Announces FDA Clearance of Centroid™
2020 25 Jun
Wearable, Wireless Patient Orientation, Activity, and Respiration Sensor Helps Clinicians Monitor Patient Position and Respiration Rate Masimo announced today that Centroid™, a wearable, wireless patient orientation, activity, and respiration rate sensor, has received FDA clearance. Centroid helps clinicians monitor patient position to avoid... Read more
Masimo Announces Masimo SafetyNet-Open™
2020 19 Jun
Suite of Integrated Turnkey Tools Helps Businesses, Governments, and Schools Reopen and Stay Open Responsibly During COVID-19 IRVINE, Calif.--( BUSINESS WIRE )-- Masimo (NASDAQ: MASI) today announced Masimo SafetyNet-Open™, designed to help businesses, governments, and schools more responsibly manage employee and student health and safety... Read more
New Agreement Brings Masimo NomoLine® Capnography & O3® Regional Oximetry to Select Philips Monitors
2020 27 May
Masimo and Royal Philips , both global leaders in patient monitoring, announced today that they have reinforced their partnership, whereby Philips will integrate additional Masimo measurement technologies into select IntelliVue® MX-series multi-parameter monitors, to help clinicians assess cerebral oximetry and ventilation status. Core Masimo... Read more
Masimo & Dräger Expand Licensing Agreement to Add Masimo Brain Monitoring & Capnography Technologies
2019 19 Dec
Masimo and Dräger announced today that they have expanded their partnership, whereby Dräger will integrate additional Masimo measurement technologies into Dräger’s family of multi-parameter patient monitors, to help clinicians assess brain function, oxygenation, and ventilation status. This press release features multimedia. View the full release... Read more
Multicenter Study Evaluates Trend Accuracy of Three Hb Monitoring Methods, including Masimo SpHb
2019 09 Dec
Masimo announced today that in a multicenter study recently published in the Journal of Clinical Monitoring and Computing, researchers at three institutions – Loma Linda University in California (LLU), the University of California at Irvine (UCI), and Mayo Clinic in Jacksonville, Florida (MCF) – evaluated the trend accuracy of three hemoglobin (Hb)... Read more
Study: Masimo Patient SafetyNet™ & Rainbow Acoustic Monitoring® In Postop Desaturation & Bradypnea
2019 21 Nov
Masimo announced today that in a study recently published in the Journal of Clinical Monitoring and Computing, researchers at Nippon Medical School in Tokyo, Japan used Masimo Patient SafetyNet™ and rainbow Acoustic Monitoring® (RAM®), acoustic respiration rate monitoring with RRa®, as a centralized continuous monitoring system to identify the incidence... Read more
Masimo: CE Marking Of Radius Capnography™ For The Root® Patient Monitoring And Connectivity Platform
2019 31 Oct
Radius Capnography with Bluetooth® Connectivity Seamlessly Integrates Tetherless Mainstream Capnography on Root Masimo announced today that Radius Capnography™, a portable real-time capnograph with wireless Bluetooth® connectivity, has received CE marking. Radius Capnography connects with the Root® Patient Monitoring and Connectivity Platform... Read more
Masimo Announces Development Of Delta CHb, HHb, And O2Hb Indices For O3®
2019 09 Sep
Masimo announced today three additional indices (delta cHb, delta HHb, and delta O2Hb) for O3® Regional Oximetry . These indices provide clinicians with additional visibility into changes in the underlying oxyhemoglobin and deoxyhemoglobin components used to calculate cerebral oxygen saturation, rSO2. With these additions, clinicians will now be... Read more
Masimo Announces Pathway™ For The Root® Patient Monitoring And Connectivity Platform
2019 04 Sep
Masimo today announced Pathway™, a feature for the Root® Patient Monitoring and Connectivity Platform . Pathway provides clinicians with a way to visualize a hospital’s recommended resuscitation protocol for a newborn’s oxygen saturation (SpO2) while continuously monitoring SpO2 and pulse rate (PR) during the first ten minutes after birth. Use of... Read more
Study: The Utility Of Masimo ORi™ To Reduce Hyperoxia In Critically Ill Patients
2019 26 Aug
Masimo announced today that in a randomized controlled study involving 150 ICU patients recently published as a letter in Intensive Care Medicine, researchers investigated whether monitoring with Masimo ORi™ (Oxygen Reserve Index) could reduce the time critically ill patients spend with moderate hyperoxia, compared to monitoring with oxygen saturation... Read more
Masimo and Mindray Announce Expanded Partnership
2019 13 May
Mindray to Offer Masimo SET ® Pulse Oximetry in its Patient Monitoring Devices in Additional Countries Beyond the United States. Masimo and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. announced today that they have entered into a purchase and license agreement, under which Mindray will offer Masimo SET® Measure-through Motion... Read more
Study Investigates Impact Of General Ward Clinical Monitoring Using Masimo Root®& Patient SafetyNet™
2018 03 Aug
Masimo has announced the findings of a recently published study in which researchers at Dartmouth-Hitchcock Medical Center investigated the impact of an integrated clinical monitoring system, using various Masimo technologies and devices, on clinical workflow and patient care in the general ward. The researchers sought to “demonstrate the application... Read more
New Study Investigates The Utility Of Masimo PVi® In Patients Undergoing Colorectal Surgery
2018 18 Jul
Masimo Radical-7® with PVi®, SpHb®, and RD rainbow SET™ Masimo (NASDAQ: MASI) has announced the findings of a recently published study in which researchers at Kocaeli University in Turkey compared the performance of conventional fluid management (CFM) to goal-directed fluid management (GDFM) using Masimo PVi® (pleth variability index, measured... Read more
Masimo Announces Vital Signs Check Application For The Root® Patient Monitoring Platform
2018 09 Jul
Masimo has announced the worldwide release of the Vital Signs Check Application, an integrated patient data collection and workflow application for the Masimo Root® patient monitoring and connectivity platform. Vital Signs Check, available for new and existing Root customers through a software upgrade, augments Root’s versatility by helping to automate... Read more
Masimo And PositiveID Announce The U.S. Release Of TIR-1™
2018 20 Jun
Masimo and Thermomedics, a PositiveID company, has announced the debut and U.S. market release of TIR-1™, a non-contact Bluetooth®-enabled thermometer that integrates seamlessly with the Masimo Root® patient monitoring and connectivity platform. TIR-1 is an easy-to-use, clinical-grade infrared thermometer that provides forehead temperature measurements... Read more
Masimo SET® Pulse Oximetry Helps Form Basis Of Utah Senate Resolution
2018 08 May
The Utah State Legislature and Governor Gary Herbert have recently signed into law the Concurrent Resolution on Deaths From Opioid-Induced Postoperative Respiratory Depression (SCR4). The resolution urges hospitals, clinicians, and researchers to examine and identify possible links between opioids and respiratory depression following surgery and encourages... Read more
Masimo O3® Regional Oximetry and SedLine® Brain Function Monitoring Power Two Investigations
2018 03 May
Masimo has announced the use of Masimo technologies – O3® regional oximetry and SedLine® brain function monitoring – in two abstracts presented at the 2018 Annual Meeting of the International Anesthesia Research Society(IARS). Both studies investigated links between postoperative delirium and particular biomarkers. In the first study 1 , Dr. Aymen... Read more
Study Investigates the Utility of Masimo SpHb® in Post-operative Red RBC Transfusion Best Practices
2018 23 Apr
Masimo announced today the findings of an abstract presented at the 2018 Annual Meeting of the Network for the Advancement of Patient Blood Management, Haemostatis and Thrombosis (NATA), in which researchers investigated the utility of Masimo noninvasive and continuous hemoglobin (SpHb®) in supporting and enhancing red blood cell (RBC) transfusion... Read more
New Study Investigates the Performance of Masimo SpHb®
2018 12 Mar
Masimo announced today the findings of a recently published study in which researchers at Cairo University in Egypt evaluated the accuracy and trending of Masimo noninvasive and continuous hemoglobin (SpHb®), referenced to an invasive laboratory hemoglobin (Lab-Hb) measurement, during acute bleeding and after fluid resuscitation. In the study,... Read more
Masimo Announces Replica™
2018 06 Mar
Today at the 2018 HIMSS Annual Conference, Masimo announced the release of Replica™, an application for smart phones and tablets that works in conjunction with Masimo Patient SafetyNet™*, a supplemental remote monitoring and clinician notification system. Replica allows clinicians to view continuous monitoring data for multiple patients, as well... Read more
Leading Nephrology Care Center in India Adopts Masimo Technologies Across Continuum of Care
2018 28 Feb
Masimo announced today that NU Hospitals, a leading nephrology care center in India, has standardized on Masimo technologies across the continuum of care. NU Hospitals have entered into a strategic partnership with Masimo to adopt technologies in their operating rooms (ORs), intensive care units (ICUs), dialysis beds, and general wards at both of their... Read more
New Study Evaluates the Performance of Masimo PVi® as a Predictor of Fluid Responsiveness
2018 12 Feb
Masimo announced today the findings of a recently published study in which researchers at Bülent Ecevit University in Zonguldak, Turkey compared two noninvasive methods of predicting fluid responsiveness in mechanically ventilated patients in the intensive care unit (ICU): Masimo PVi® (pleth variability index, measured noninvasively and continuously... Read more
Masimo Announces U.S. Release of Trace™ Data Visualization and Reporting Tool
2017 07 Oct
Masimo Trace™ Data Visualization and Reporting Tool Masimo has announced that the U.S. release of Trace™, patient data visualization and reporting software designed for Masimo Root® and Radical-7® monitors. Trace is the first data visualization and reporting software compatible with the full capabilities of the Masimo Root Patient... Read more
Masimo announces full market release of Rainbow Acoustic Monitoring Sensor RAS-45
2017 02 Oct
Masimo rainbow Acoustic Monitoring® RAS-45 Acoustic Respiration Sensor Masimo has announced the full market release of RAS-45, an adhesive adult and pediatric acoustic respiration sensor for rainbow Acoustic Monitoring® (RAM™). RAS-45 offers the same performance as the currently available RAS-125c sensor but in a smaller size, with more flexible... Read more
Newborn Foundation and Masimo Partnership Reaches 52,000 Babies and 1,000 Health Workers
2017 19 Sep
BORN Project convenes public health stakeholders to highlight key program successes at three-year mark, reinforcing global call to action to support universal newborn pulse oximetry screening as a tool to significantly reduce newborn mortality and drive treatment infrastructure in low-resource settings. Masimo (NASDAQ: MASI) and the Newborn... Read more
Study Investigates Performance of Masimo PVi® As Part of Goal-Directed Fluid Therapy
2017 29 Aug
Masimo has announced the findings of a recently published study in which researchers at Firat University in Turkey evaluated the performance of Masimo PVi®, a noninvasive and continuous measurement of the dynamic changes in perfusion index (Pi) that occur during respiratory cycles, as the basis of a goal-directed fluid therapy (GDFT) protocol during... Read more
Study Evaluates Performance of Masimo SpHb® in Trauma Patients with Low Hemoglobin Levels
2017 10 Aug
Masimo has announced the findings of a recently published study in which researchers at Cairo University in Egypt evaluated the performance of Masimo SpHb®, noninvasive, continuous hemoglobin measurement, in trauma patients with low hemoglobin levels. 1 In the prospective, observational study, Dr. Gamal and colleagues sought to evaluate SpHb measurements... Read more
Comparison of Masimo Acoustic Respiration Rate (RRa®) and Nellcor Plethysmographic Respiration Rate
2017 01 Aug
Masimo Radical-7® Pulse CO-Oximeter® with RAS-125c Respiratory Acoustic Sensor Masimo has announced that researchers at the Tokyo Women’s Medical University, Department of Anesthesiology, in Japan have published a study investigating the measurement of respiration rate in volunteers. Masimo acoustic respiration rate (Masimo), using the Masimo... Read more
Masimo Announces CE Marking of Noninvasive RPVi™
2017 28 Jul
Masimo Radical-7® Pulse CO-Oximeter® with RPVi™ Masimo has announced the CE marking of RPVi™, a noninvasive and continuous measurement of the dynamic changes in perfusion index (Pi) that occur during one or more respiratory cycles. RPVi is designed to show changes that reflect physiologic factors such as vascular tone, circulating blood... Read more
Study Compares Performance of Masimo Next Generation SedLine® PSi to Original PSi During Anesthesia
2017 29 Jun
Masimo has announced the findings of an abstract presented at Euroanaesthesia 2017 in Geneva, Switzerland. In the study, researchers at University Medical Center Groningen, Netherlands, compared original and Next Generation versions of Masimo Patient State Index (PSi, a processed EEG parameter related to the effect of anesthetic agents) during... Read more
New Study Investigates the Clinical Utility of ORi™, Masimo Oxygen Reserve Index™
2017 14 Jun
Masimo has announced the findings of an abstract presented at the recent International Anesthesia Research Society (IARS) Annual Meeting in Washington, DC. In the study, researchers at the UC Davis School of Medicine evaluated the potential clinical utility of Masimo Oxygen Reserve Index™ (ORi™) as an early warning of arterial hemoglobin desaturation... Read more
Masimo Announces Limited Market Release of Rad-67™ rainbow® Pulse CO-Oximeter®
2017 06 Jun
Masimo has announced, in conjunction with its CE marking, the limited market release of the Spot-Check Rad-67™ Handheld Pulse CO-Oximeter®. Rad-67 offers Measure-through Motion and Low Perfusion™ SET® pulse oximetry and upgradeable rainbow® noninvasive monitoring technology in a compact, portable spot-check device. With the universal reusable rainbow® DCI®-mini... Read more
Masimo & Mdoloris Announce Masimo Open Connect™ Partnership
2017 01 Jun
Analgesia Nociception Index (ANI ® ) Module for Root to be Previewed at the European Society of Anaesthesiology in Geneva, SwitzerlandJune 3 – 5, 2017 Masimo and Mdoloris Medical Systems has announced a Masimo Open Connect™ (MOC) partnership for the Root® Open Architecture Patient Monitoring and Connectivity Hub, in which Mdoloris is developing... Read more
Masimo Announces FDA 510(k) Clearance of O3™ Regional Oximetry for Pediatric Patients
2017 30 May
Masimo announced today FDA 510(k) clearance for the pediatric indication for O3™ regional oximetry with the O3 pediatric sensor. Regional oximetry, also referred to as tissue or cerebral oximetry, may help clinicians monitor cerebral oxygenation in situations in which peripheral pulse oximetry alone may not be fully indicative of the oxygen in the... Read more
Masimo Announces the Full Market Release of Early Warning Score (EWS)
2017 19 May
Masimo Root® Patient Monitoring and Connectivity Hub with Early Warning Score (EWS) Masimo has announced the full market release of Early Warning Score (EWS) on the Root® patient monitoring and connectivity hub. EWS aggregates information from multiple vital signs and clinical observations to generate a score that represents the potential degree... Read more
Multicenter Study Evaluates the Trend Accuracy of Masimo Continuous SpHb®
2017 17 May
Masimo has announced the findings of an abstract presented at the International Anesthesia Research Society (IARS) Annual Meeting in Washington, DC. In the multicenter study, researchers at three academic medical centers evaluated the trend accuracy of noninvasive, continuous hemoglobin monitoring (SpHb®). 1 The prospective observational study... Read more
Masimo Announces Full Market Release of Root® Patient Monitor and Connectivity Hub
2017 11 Apr
Masimo Root® Patient Monitor and Connectivity Hub with Kite™ Supplemental Display System (Photo: Business Wire) Masimo has announced to the full market release of Root® with Kite™, a supplemental display system. Kite expands visibility of patient data for clinicians by allowing data from Root to be viewed on bigger screens, in customized configurations,... Read more
Masimo Announces CE Marking of Rad-97™ Pulse CO-Oximeter® & Connectivity Hub
2017 20 Mar
Masimo Rad-97™ Pulse CO-Oximeter® and Connectivity Hub with Noninvasive Blood Pressure Masimo has announced the CE marking of noninvasive blood pressure (NIBP) measurements for the Rad-97™ Pulse CO-Oximeter® and connectivity hub. Rad-97 offers Measure-through Motion and Low Perfusion™ SET® pulse oximetry and upgradeable rainbow® noninvasive... Read more
New Study Evaluates the Utility of Masimo SpHb® Monitoring During Liver Transplantation
2017 19 Mar
Masimo has announced the publication of a recent study conducted on adult patients undergoing liver transplantation (LT), in which researchers assessed the accuracy and trending ability of noninvasive Masimo SpHb® (total hemoglobin) measurement, as compared to conventional laboratory hemoglobin (HbL) measurements. The researchers found that SpHb... Read more
Masimo Announces Availability of the RD SedLine® Adult EEG Sensor
2017 07 Mar
Masimo has announced availability of the RD SedLine® EEG sensor, for use with Masimo SedLine Brain Function Monitoring and compatible with simultaneous use of Masimo O3™ Regional Oximetry. SedLine and O3 provide simultaneous monitoring on the Masimo Root® monitoring platform, helping to give clinicians more information about the brain. The... Read more
New Study Assesses the Utility of Masimo PVi® Monitoring During Colorectal Surgery
2017 27 Feb
Masimo has announced the findings of a recent study conducted on low-risk patients undergoing colorectal surgery, in which researchers assessed the utility of noninvasive and continuous Masimo PVi® (Pleth Variability Index) monitoring to guide fluid management, as compared to esophageal Doppler, an invasive method. The researchers found no significant... Read more
Masimo Announces Recent Study Monitoring Methemoglobin Levels
2017 26 Feb
Masimo has announced the findings of a recent study conducted on children admitted to a Ugandan hospital with fever and malaria, in which Masimo’s noninvasive measurement SpMet® was used to monitor methemoglobin (MetHb) levels. One group of children with severe malaria was selected to receive inhaled nitric oxide (iNO) treatment as an adjunct to... Read more
Masimo Announces the Addition of Early Warning Score to the Root® Patient Monitoring Platform
2017 02 Feb
Masimo announced today the limited market release of Early Warning Score (EWS) on the Root® patient monitoring and connectivity platform. EWS aggregates information from multiple vital signs and clinical observations to generate a score that represents the potential degree of patient deterioration. Root, which works in conjunction with Radical-7® or... Read more
Masimo Announces FDA 510(k) Clearance for TFA-1TM Single-Patient-Use Forehead Senso
2016 19 Dec
Masimo announced today FDA 510(k) clearance for the TFA-1™ Single-Patient-Use Adhesive Forehead Sensor. This single-patient-use sensor allows clinicians to monitor patients using Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry from an alternative monitoring site, the forehead, rather than a finger. Masimo TFA-1 Single-Patient-Use... Read more
Masimo Receives Gates Foundation Grant to Develop Combined Pneumonia-Screening Device
2016 13 Nov
Masimo has announced, in advance of World Pneumonia Day tomorrow, that it has received a grant of $4.95 million from the Bill & Melinda Gates Foundation (BMGF). The grant will support Masimo’s efforts to develop a low-cost pulse oximeter for use in pneumonia screening in several low-resource areas outside the U.S. While still in development, the... Read more
Philips & Masimo Sign Multi-Year Agreement in Patient Monitoring & Select Therapy Solutions
2016 07 Nov
Multi-year business partnership combines Masimo’s expertise in non-invasive sensor and signal processing technologies and Philips’ expertise in integrated patient monitoring and therapy solutions Business partnership involves technology integration and marketing and sales cooperation in North America and certain markets in Asia and Europe Agreement... Read more
Adam Mikkelson of Camber Capital Management Joins Masimo’s Board of Directors
2016 28 Oct
Masimo (NASDAQ: MASI), a global innovator of noninvasive patient monitoring technologies, announced today that Adam Mikkelson, Partner at Camber Capital Management, LLC, has been elected to Masimo’s Board of Directors. Mr. Mikkelson has been with Camber Capital Management, a healthcare-focused investment fund, since 2007. He has almost 15 years... Read more
Study Investigates the Impact of Masimo Continuous SpHb® and PVI® on Anesthesia-Related Mortality
2016 24 Oct
Masimo has announced the findings of an abstract presented at the American Society of Anesthesiologists’ (ASA) Annual Meeting in Chicago. In the study, researchers at Hôpital Dupuytren, part of the Centre Hospitalier Universitaire of Limoges, France (CHU Limoges), investigated the clinical utility of noninvasive, continuous hemoglobin (SpHb®) and... Read more
WFSA Signs Commitment to Support Patient Safety Movement’s Mission of Zero Patient Deaths by 2020
2016 19 Oct
Patient Safety Movement Foundation Joins WFSA’s SAFE-T Campaign The World Federation of Societies of Anaesthesiologists (WFSA) has signed a commitment to action and announced that it will support the Patient Safety Movement Foundation (PSMF) and its mission to eliminate preventable deaths by the year 2020. Concurrently, the PSMF... Read more
Masimo Partners with Smile Train to Advance Safe Surgery
2016 30 Sep
Masimo has announced that it is partnering with Smile Train to help ensure the safety of patients undergoing cleft lip and/or palate surgery in low-resource settings around the world. Patient monitoring, including the use of pulse oximetry, is a key part of ensuring safe surgical care; however, in lower-resource settings essential monitoring equipment... Read more
Masimo Announces a Special Worldwide Program for SpHb® Monitoring for Zika Virus Affected Areas
2016 29 Sep
Masimo has announced that in response to the Zika virus and its potential impact on the availability of blood products, Masimo is creating a special program to dramatically reduce the cost of and increase access to Masimo’s continuous hemoglobin monitoring (SpHb ® ) solutions, shown to help clinicians reduce blood transfusions in both low and... Read more
Masimo Announces Four-Year Partnership with World Federation of Societies of Anaesthesiologists
2016 29 Sep
Joint Initiative, “Safe Anaesthesia – ASAP,” Is to Improve Anesthesia Care in Low Resource Countries Masimo has announced at the World Congress of Anaesthesiologists (WCA) in Hong Kong that it has become the first Global Impact Partner of the World Federation of Societies of Anaesthesiologists (WFSA) . The four-year partnership, “Safe Anaesthesia... Read more
Study on Abdominal Surgical Patients Investigates Clinical Utility of Masimo PVI®
2016 15 Sep
Masimo has announced the findings of a study recently presented at the World Congress of Anesthesiologists (WCA) in Hong Kong. In the study, researchers at Cairo University in Egypt investigated the clinical utility of a Masimo SET ® noninvasive, continuous measurement, PVI®. In the prospective study of 60 adult patients undergoing major abdominal... Read more
Noninvasive Hemoglobin Monitoring Using Masimo SpHb® May Reduce Red Blood Cell Transfusion
2016 09 Sep
Masimo has announced that in a new study recently presented at the World Congress of Anesthesiologists (WCA) in Hong Kong, researchers concluded that continuous and noninvasive hemoglobin monitoring using Masimo SpHb® may reduce excessive intraoperative red blood cell (RBC) transfusion. 1 In a retrospective review of 371 patients who underwent... Read more
Masimo Announces CE Marking for Pediatric O3™ Regional Oximetry
2016 04 Aug
Masimo has announced the CE marking for the pediatric indication for O3™ regional oximetry with the O3 pediatric sensor. Regional oximetry, also referred to as tissue or cerebral oximetry, helps clinicians monitor cerebral oxygenation. O3 regional oximetry uses near-infrared spectroscopy (NIRS) to continuously monitor absolute and trended regional... Read more
Ohio Critical Access Hospital Adopts Masimo Root® with Radius-7®, Radical-7®,& Patient SafetyNet™
2016 28 Jul
Masimo has announced that University Hospitals Geneva Medical Center (UH Geneva), a Critical Access Hospital in Geneva, Ohio, is building a hospital-wide wireless monitoring and clinician notification system using Masimo Patient SafetyNet™* in conjunction with Masimo Root® with Radius-7® and Masimo Radical-7®. UH Geneva is part of University Hospitals,... Read more
New Study Evaluates Masimo PVI® as a Predictor of Fluid Responsiveness
2016 28 Jul
Masimo has announced that a new study of patients undergoing liver transplantation evaluated the relationship of PVI® to right ventricular end-diastolic volume (RVEDVI) and concluded that PVI provided a “reliable estimate of [cardiac] preload status and may be a useful predictor of fluid responsiveness.” 1 PVI measures the dynamic changes in perfusion... Read more
New Study Assesses Utility of 1st Generation Masimo Pronto® Pulse CO-Oximeter® with SpHb® Spot
2016 15 Jul
Masimo has announced that in a new study using the 1st Generation Masimo Pronto® Pulse CO-Oximeter®, which noninvasively measures total hemoglobin (SpHb®), researchers found that noninvasive and invasive measurements correlated well and that “[g]iven the rapid availability of results and the lack of requirement of venipuncture, noninvasive hemoglobin... Read more
DHZB Adopts Masimo’s SedLine® Brain Function Monitoring & O3™ Regional Oximetry
2016 08 Jul
Masimo has announced that Deutsches Herzzentrum Berlin (DHZB / German Heart Center Berlin) in Berlin, Germany, has adopted Masimo’s SedLine® Brain Function Monitoring and O3™ Regional Oximetry technologies to monitor patients in the operating room and intensive care unit. “Our non-profit hospital performs over 32,000 treatments each year. Easy... Read more
Masimo Announces FDA 510(k) Clearance for Radius-7® with rainbow® Technology
2016 28 Jun
Radius-7 is the First Wearable, Tetherless, Noninvasive rainbow® Monitor Masimo has announced FDA 510(k) clearance for Radius-7® – the first and only wearable, tetherless, noninvasive rainbow® monitor. Radius-7, which connects to the Root® patient monitoring and connectivity platform, is now available in the U.S. with breakthrough Masimo rainbow® techno Read more
New SunTech Medical CT40 Vital Signs Device to Feature Masimo SET® Pulse Oximetry Technology
2016 23 Jun
Masimo and SunTech Medical, a Halma (LSE:HLMA) company, jointly has announced the integration of Masimo SET® pulse oximetry technology into SunTech’s CT40, a next generation spot-check vital signs device. Masimo Signal Extraction Technology (SET®) Measure-through Motion and Low Perfusion™ pulse oximetry measures oxygen saturation (SpO2), pulse rate,... Read more
Masimo Announces 510(k) Clearance for O3™ Regional Oximetry
2016 13 Jun
Masimo has announced FDA 510(k) clearance for O3™ regional oximetry. Regional oximetry, also referred to as tissue or cerebral oximetry, may help clinicians monitor cerebral oxygenation in situations in which pulse oximetry alone may not be fully indicative of the oxygen in the brain due to various factors, such as the type of clinical procedure being... Read more
Masimo Announces Full Market Release of Next Generation SpHb® Spot Check Pronto®
2016 08 Jun
Masimo has announced the full market release outside the U.S. of the Pronto® Pulse CO-Oximeter® with Next Generation SpHb® Spot Check technology. Next Generation Pronto features rainbow SET™ technology, for noninvasive spot checking of total hemoglobin (SpHb), oxygen saturation (SpO2), pulse rate (PR), and perfusion index (PI). In addition to the... Read more
ESA Partners with Patient Safety Movement to Lead the Movement to Zero Preventable Deaths in Europe
2016 06 Jun
The European Society of Anaesthesiology (ESA) and the Patient Safety Movement Foundation has announced that on May 28, 2016 at the annual congress Euroanaesthesia 2016 in London, the ESA made a public commitment to lead the Patient Safety Movement in over 50 countries in Europe. “As clinicians, our number one focus is Patient Safety,” said Dr.... Read more
India’s Motherhood Hospitals, Standardizes on Masimo SET® Technology
2016 02 Jun
Masimo has announced that Motherhood Hospitals, a maternal care specialist with five hospitals in three cities in India, has standardized on Masimo SET® (Signal Extraction Technology) pulse oximetry at all locations. Motherhood Hospitals will also be screening for Critical Congenital Heart Disease (CCHD) using Masimo’s technology. “We are happy... Read more
Masimo to Showcase Next Generation SedLine® Brain Function Monitor at 2016 Euroanaesthesia Congress
2016 27 May
SedLine, Which Helps Clinicians Improve Anesthetic Management, Receives CE Mark Masimo announced today the CE mark and scheduled full market release of Next Generation SedLine® Brain Function Monitoring technology at the European Society of Anaesthesiology's (ESA) 2016 Euroanaesthesia Congress in London, England. Next Generation SedLine enhances... Read more
Two Fire Departments Honored for Excellence in Emergency Medical Services
2016 19 May
Fire-Service Based EMS Awards Presented at 28 th Annual National Fire and Emergency Services Dinner The Congressional Fire Services Institute (CFSI) and Masimo honored two fire departments for best practices and innovative solutions in the delivery of emergency medical services with the Excellence in Fire Service-Based EMS Award. The award... Read more
Masimo Reports First Quarter 2016 Financial Results
2016 09 May
Q1 2016 Highlights (compared to Q1 2015): Total revenue, including royalties, rose 10.8% to $171.2 million Product revenue rose 10.8% to $163.3 million Masimo rainbow® revenue rose 39.2% to $16.9 million SET® and rainbow® SET® units shipments were 46,300 GAAP net income of $27.6 million, or $0.53 per diluted share versus $20.5 million, or $0.38... Read more
France’s University Hospitals Adopts Masimo Radical-7®,Including SpHb®,PVI®,& SET® Pulse Oximetry
2016 21 Apr
Masimo (NASDAQ: MASI) has announced that Centre Hospitalier Universitaire (CHU) de Limoges, in Limoges, France has installed Masimo’s Radical-7®, including noninvasive, continuous hemoglobin (SpHb®), Pleth Variability Index (PVI®), and SET® pulse oximetry technology, to monitor surgical patients and critical patients in the post-anesthesia care unit... Read more
Study on Relationship Between Masimo’s ORI™& Arterial Partial Pressure of Oxygen During Surgery
2016 31 Mar
Masimo has announced that a new retrospective study reports the relationship between Masimo’s Oxygen Reserve Index (ORI™) and arterial partial pressure of oxygen (PaO 2 ) during surgery. The study suggests that ORI may provide an advanced indication of impending desaturation in adults undergoing surgery based on trends in the relationship between... Read more
Accuracy of Masimo’s Blue®Sensors at Saturations below 85% in Children with Cyanotic CHD
2016 22 Mar
Masimo has announced that a new study reported on the accuracy of Masimo’s Blue® sensors as compared to Nellcor and Masimo Standard sensors for cyanotic children with blood oxygen saturation less than 85%. 1 Masimo’s Blue sensor was designed specifically for cyanotic infants and children with congenital heart disease. The study was performed at... Read more
Masimo Introduces SafetyNet™ Surveillance at HIMSS16
2016 07 Mar
Patient Video Surveillance System Provides High-Definition Real-Time Imaging at the Bedside Masimo has announced the debut of SafetyNet™Surveillance at the HIMSS (Healthcare Information and Management Systems Society) 2016 Annual Conference and Exhibition in Las Vegas. SafetyNet Surveillance is a video surveillance system that provides real-time... Read more
Masimo Announces Iris™ Gateway at HIMSS16
2016 07 Mar
Integrated Medical Device Data Management Solution Designed to Fill the Gaps in Electronic Medical Records Masimo has announced the debut of Iris™ Gateway, a server-based software solution for integrating medical device data, at the HIMSS (Healthcare Information and Management Systems Society) 2016 Annual Conference and Exhibition in Las Vegas.... Read more
Manipal Hospitals is the First in India to Adopt Masimo Patient SafetyNet™
2016 07 Mar
Masimo has announced that Manipal Hospitals is the first hospital in India to install Masimo Patient SafetyNet™, a remote monitoring and clinician notification system. "With Patient SafetyNet, we are now able to monitor a certain set of patients 24x7," said Gopal Devanahalli, Chief Operating Officer of Manipal Hospitals. "One of the key features... Read more
Masimo Announces FDA 510(k) Clearance for Root® with Noninvasive Blood Pressure and Temperature
2016 07 Mar
Masimo announced today FDA 510(k) clearance for noninvasive blood pressure and temperature measurements for the Root® patient monitoring and connectivity platform. Root with noninvasive blood pressure from SunTech Medical enables clinicians to measure arterial blood pressure for adult, pediatric, and neonatal patients, with three distinct measurement... Read more
Masimo's rainbow® Acoustic Monitoring was Associated with Fewer Alarm Events in New Clinical Study
2016 24 Feb
For Breath Rates Less Than or Equal to 4 Breaths Per Minute, RAM Showed 78% True Positives and 22% False Positives, While Capnography Showed 30% True Positives and 70% False Positives Masimo (NASDAQ: MASI) has announced that Masimo's rainbow®Acoustic Monitoring (RAM™) was associated with fewer alarm events during planned moderate sedation in a... Read more